Dr. Brian D Raineri, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 63 Suncrest Ave, North Haledon, NJ 07508 Phone: 973-238-0549 Fax: 973-355-8677 |
Dr. Daniel Rojas, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 467 High Mountain Rd, North Haledon, NJ 07508 Phone: 973-427-6300 |
Dr. Tania Rotoli I, PHARM D, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 467 High Mountain Rd, North Haledon, NJ 07508 Phone: 973-427-6300 Fax: 973-427-7579 |
Sally E. Amer Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 64 Linda Vista Ave, North Haledon, NJ 07508 Phone: 973-417-6359 |
Oksana Zatuchny Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 42 Magnolia Way, North Haledon, NJ 07508 Phone: 201-921-2400 |
Mrs. Christine Elizabeth Hayes, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9 Pinecliff Ct, North Haledon, NJ 07508 Phone: 973-310-3055 |
News Archive
Researchers at GlaxoSmithKline (GSK) in Italy and Belgium say the coronavirus disease 2019 (COVID-19) pandemic is transforming the world of vaccinology by accelerating vaccine development and the availability of powerful technologies.
As the health insurance reform debate continues in Washington, D.C. and around the country, Summa Health System provides the following response to the latest developments in the debate and the potential impact on Summa. As a system, Summa continues to inform the debate by sharing its perspective on various policy changes and urges adoption of policies that would impact its patients' health in a positive way, including efforts to expand affordable health insurance to those without coverage.
Harvard Bioscience, Inc., a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, has filed two major patents in the field of regenerative medicine, the first covering 61 claims for its stem cell therapy injectors and the second for 338 claims for bioreactors for organ growth.
Childrens Hospital Los Angeles has been awarded $7 million of a $56.8 million grant from the National Institutes of Health. The remainder of the award will be distributed to other members of the Los Angeles Basin Clinical and Translational Science Institute (CTSI). This award, to be distributed over five years, will fund biomedical research with the objective of reducing the time it takes a laboratory discovery to become a clinical reality.
Lymphoma Foundation Canada (LFC) applauds Ontario's recent decision to publicly fund Rituxan (rituximab) in combination with Fludarabine-based chemotherapy for patients with previously untreated chronic lymphocytic leukemia (CLL).
› Verified 5 days ago